Noticias de NTLA_US
Noticias del mercado
Últimas noticias sobre NTLA_US — 284 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
ARK Investment Acquires Shares in Intellia Therapeutics (NTLA)
Intellia Therapeutics launches $150 million stock offering
ARK Investment Acquires Shares in Intellia Therapeutics (NTLA)
Intellia Therapeutics Inc (NTLA) Stock Price, Trades & News
Why The Narrative Around Intellia Therapeutics (NTLA) Is Shifting After FDA Hold Resolutions
Cathie Wood’s ARK sells Rocket Lab, buys Intellia stock
Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med
Intellia Therapeutics, Inc. has filed an IPO.
Intellia Therapeutics (NTLA) Launches $150M Public Offering
Chardan raises Intellia Therapeutics price target on phase 3 data By Investing.com
Intellia Therapeutics launches $150M public stock offering
El ensayo HAELO en angioedema hereditario mostró una tasa de reducción de ataques del 87% y podría convertirse en el primer medicamento de edición de genes CRISPR in vivo en obtener la aprobación de la FDA.
Intellia Heads To FDA With Positive Phase III Results For Lonvo-Z
Chardan raises Intellia Therapeutics price target on phase 3 data By Investing.com
Intellia Announces Proposed Public Offering of Common Stock
Gene-editing drug developer Intellia seeks $150M in stock sale
Press Release: Intellia Announces Proposed Public Offering of Common Stock
Página 7 de 15
